Peripheral ulcerative keratitis and Mooren ulcer
A painful crescent ulcer that thins the edge of the cornea. It often signals active systemic vasculitis, such as rheumatoid arthritis.
What it is
Crescent-shaped inflammatory destruction of the peripheral corneal stroma next to the limbus, with an epithelial defect. About half of cases accompany systemic autoimmune disease, mostly rheumatoid arthritis and ANCA vasculitis, and may herald fatal vasculitis. Mooren ulcer is the idiopathic, very painful form.
Who gets it
Rare, with an estimated incidence of about 3 per million per year. Rheumatoid arthritis is the most common systemic association. Mooren ulcer is more common in men, and bilateral aggressive forms are reported in young men from Africa, Asia and other tropical regions.
Causes
- Rheumatoid arthritis (most common)
- Granulomatosis with polyangiitis and other ANCA vasculitides
- Polyarteritis nodosa, systemic lupus erythematosus, relapsing polychondritis
- Infections (herpes, bacteria, hepatitis C)
- Mooren ulcer: idiopathic autoimmune reaction to a corneal stromal antigen
Risk factors
- Long-standing, poorly controlled rheumatoid arthritis
- Active systemic vasculitis
- Ocular surgery or trauma (Mooren ulcer)
- Hepatitis C and helminth infections (Mooren ulcer in some regions)
Pathophysiology
The peripheral cornea receives immune complexes and inflammatory cells from limbal vessels. Immune complex deposition activates complement and recruits neutrophils, which release collagenases and matrix metalloproteinases that digest the stroma. Ongoing vasculitis keeps the process active until the cornea melts or perforates.
Classification
- Associated with systemic autoimmune disease or vasculitis
- Infectious
- Mooren ulcer (diagnosis of exclusion): limited unilateral, or bilateral aggressive
Symptoms and signs
- Pain, often severe (especially Mooren ulcer)
- Redness, watering and light sensitivity
- Crescent ulcer at the corneal edge with stromal thinning
- Overhanging edge on the central side in Mooren ulcer
- Adjacent scleritis in some patients
Diagnosis
- Clinical
- Slit-lamp examination with fluorescein shows an epithelial defect with peripheral stromal thinning; examine the sclera; full systemic history and examination.
- Tests
- Full blood count, kidney function and urinalysis, inflammatory markers, rheumatoid factor and anti-CCP, ANCA, ANA, hepatitis B and C serology, syphilis serology; corneal scraping and culture to exclude infection.
- Imaging
- Anterior segment optical coherence tomography to measure thinning; chest radiograph or CT and sinus imaging when vasculitis is suspected.
Differential diagnosis
- Marginal keratitis (clear zone, little thinning, less pain)
- Infectious keratitis
- Terrien marginal degeneration (painless, intact epithelium)
- Dellen next to a raised limbal lesion
Peripheral corneal thinning or infiltrate: which one is it?
| Feature | PUK and Mooren ulcer | Marginal keratitis | Terrien marginal degeneration |
|---|---|---|---|
| Pain | Severe | Mild to moderate | None |
| Epithelium | Defect over the thinning | Intact or a minimal defect | Intact |
| Inflammation | Marked redness, sometimes adjacent scleritis | Moderate redness near the infiltrate | Quiet eye; yellow lipid line at the leading edge |
| Thinning | Progressive, can perforate | Little or none | Slow over years, usually superior |
| Cause | Systemic vasculitis, infection, or idiopathic (Mooren) | Staphylococcal antigens from blepharitis | Idiopathic degeneration |
Goal of treatment
Stop the melting, prevent perforation and control the underlying systemic disease urgently with rheumatology.
Treatment
- Acute
- Same-day referral; lubricants, protection and topical antibiotic prophylaxis for the epithelial defect; oral tetracycline-class drug to inhibit collagenase.
- Medical
- Systemic corticosteroids plus steroid-sparing immunosuppression (methotrexate, mycophenolate, cyclophosphamide or rituximab) for vasculitis-associated PUK and Mooren ulcer.
- Surgical
- Conjunctival resection next to the ulcer, amniotic membrane, tissue adhesive, or a lamellar or patch graft for severe thinning or perforation.
Complications
- Corneal perforation
- Severe astigmatism and scarring
- Endophthalmitis after perforation
- Death from uncontrolled systemic vasculitis
Common traps
- PUK is an eye disease that drops alone can control: the melt is driven by systemic immune disease, so it needs systemic immunosuppression with rheumatology; topical treatment only protects the surface
- Quiet joints mean no systemic cause: PUK can be the first sign of granulomatosis with polyangiitis or another vasculitis, so ANCA, kidney function, urinalysis and chest imaging are checked in every patient
- Any painful peripheral ulcer is a Mooren ulcer: Mooren ulcer is a diagnosis of exclusion, made only after systemic and infectious causes have been ruled out
- All peripheral thinning is PUK: painless thinning with intact epithelium and a lipid line is Terrien degeneration; PUK is painful, inflamed and has an epithelial defect
- PUK only threatens the eye: untreated vasculitis-associated PUK carries a high mortality, so the systemic work-up is as urgent as protecting the cornea
Prognosis
Vision is often preserved with prompt systemic immunosuppression. Untreated PUK with vasculitis carries a high mortality. Bilateral aggressive Mooren ulcer is the hardest to control.
Test yourself
Think of the answer, then tap the question to see it.
A woman with long-standing rheumatoid arthritis has a painful red eye with a crescent ulcer and thinning at the corneal edge. What is the priority?
Same-day ophthalmology and urgent systemic work-up: PUK signals active vasculitis, and systemic immunosuppression with rheumatology is needed to stop the melt.
Why does PUK affect the edge rather than the centre of the cornea?
The periphery lies next to the limbal vessels, which deliver immune complexes, complement and neutrophils; their collagenases digest the nearby stroma.
A patient with PUK also has haematuria and chronic sinusitis. Which disease is likely, and which test?
Granulomatosis with polyangiitis; ANCA testing, with kidney function, urinalysis and chest imaging.
Why is an oral tetracycline-class drug added in PUK?
It inhibits collagenase and matrix metalloproteinases, slowing the stromal melt while systemic immunosuppression takes effect.
When can a diagnosis of Mooren ulcer be made?
Only after systemic autoimmune, vasculitic and infectious causes have been excluded, in a painful peripheral ulcer with an undermined central edge.
Connections
Educational information, not medical advice. For any symptom, see a health professional.
Sources: Peripheral Ulcerative Keratitis (StatPearls Publishing (NCBI Bookshelf), 2024); Mooren's Ulcer (EyeWiki, American Academy of Ophthalmology, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.

